Daniel C. Rowe

6.9k total citations · 3 hit papers
13 papers, 5.6k citations indexed

About

Daniel C. Rowe is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Daniel C. Rowe has authored 13 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Daniel C. Rowe's work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and interferon and immune responses (3 papers). Daniel C. Rowe is often cited by papers focused on Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers) and interferon and immune responses (3 papers). Daniel C. Rowe collaborates with scholars based in United States, United Kingdom and Ireland. Daniel C. Rowe's co-authors include Katherine A. Fitzgerald, Douglas T. Golenbock, Anthony J. Coyle, Eicke Latz, Tom Maniatis, Sarah M. McWhirter, Sha-Mei Liao, L. Kerrie, Ronald Herbst and Gary P. Sims and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

Daniel C. Rowe

13 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IKKε and TBK1 are essential components of the IRF3 signaling pathway

2003 2.2k citations Katherine A. Fitzgerald, Sarah M. McWhirter et al. Nature Immunology profile →
HMGB1 and RAGE in Inflammation and Cancer

2010 1.2k citations Gary P. Sims, Daniel C. Rowe et al. Annual Review of Immunology profile →
LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

2003 979 citations Katherine A. Fitzgerald, Daniel C. Rowe et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel C. Rowe United States	11	4.1k	1.6k	1.1k	809	727	13	5.6k
Christophe Van Huffel United States	13	5.3k 1.3×	1.8k 1.1×	911 0.8×	1.3k 1.6×	473 0.7×	21	7.6k
Erica Alejos United States	7	5.1k 1.2×	1.5k 0.9×	818 0.8×	1.2k 1.5×	422 0.6×	7	6.9k
Sanna M. Goyert United States	43	4.6k 1.1×	1.5k 0.9×	451 0.4×	1.3k 1.7×	436 0.6×	85	6.8k
Hayyoung Lee South Korea	24	4.1k 1.0×	2.3k 1.4×	726 0.7×	1.1k 1.4×	623 0.9×	45	6.7k
Li‐Chung Hsu Taiwan	34	2.6k 0.6×	2.7k 1.6×	1.1k 1.0×	858 1.1×	824 1.1×	81	5.9k
Hilde Cheroutre United States	54	7.8k 1.9×	2.9k 1.7×	682 0.6×	1.1k 1.4×	2.1k 2.9×	110	11.8k
Markus Munder Germany	35	3.3k 0.8×	1.5k 0.9×	408 0.4×	933 1.2×	767 1.1×	80	6.1k
Brian M. J. Foxwell United Kingdom	40	3.2k 0.8×	1.7k 1.0×	1.3k 1.2×	710 0.9×	1.0k 1.4×	69	5.8k
Joseph A. Duncan United States	35	2.7k 0.6×	3.9k 2.4×	376 0.3×	675 0.8×	385 0.5×	65	6.0k
Eyal Amiel United States	23	3.3k 0.8×	1.6k 1.0×	690 0.6×	662 0.8×	611 0.8×	39	4.9k

Countries citing papers authored by Daniel C. Rowe

Since Specialization

Citations

This map shows the geographic impact of Daniel C. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Rowe more than expected).

Fields of papers citing papers by Daniel C. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Rowe. The network helps show where Daniel C. Rowe may publish in the future.

Co-authorship network of co-authors of Daniel C. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Rowe. A scholar is included among the top collaborators of Daniel C. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Rowe. Daniel C. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rowe, Daniel C.. (2015). Periodic Reporting in a Continuous World: The Correlating Evolution of Technology and Financial Reporting. 13(1). 248–266. 2 indexed citations

Chen, Bo, Allison L. Miller, Marlon C. Rebelatto, et al.. (2015). S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo. PLoS ONE. 10(2). e0115828–e0115828. 95 indexed citations

Tian, Jane, Subramaniam Krishnan, Catherine Svabek, et al.. (2013). RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function. Journal of General Virology. 94(8). 1691–1700. 18 indexed citations

Sims, Gary P., Daniel C. Rowe, Svend T. Rietdijk, Ronald Herbst, & Anthony J. Coyle. (2010). HMGB1 and RAGE in Inflammation and Cancer. Annual Review of Immunology. 28(1). 367–388. 1164 indexed citations breakdown →

McGettrick, Anne F., Elizabeth Brint, Eva M. Pålsson‐McDermott, et al.. (2006). Trif-related adapter molecule is phosphorylated by PKCε during Toll-like receptor 4 signaling. Proceedings of the National Academy of Sciences. 103(24). 9196–9201. 112 indexed citations

Rowe, Daniel C., Anne F. McGettrick, Eicke Latz, et al.. (2006). The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proceedings of the National Academy of Sciences. 103(16). 6299–6304. 219 indexed citations

Campellone, Kenneth G., Michael J. Brady, Daniel C. Rowe, et al.. (2006). Enterohaemorrhagic Escherichia coli Tir requires a C-terminal 12-residue peptide to initiate EspFU-mediated actin assembly and harbours N-terminal sequences that influence pedestal length. Cellular Microbiology. 8(9). 1488–1503. 39 indexed citations

Shukla, Nilima, Daniel C. Rowe, J.M. Hinton, Gianni D. Angelini, & Jamie Y. Jeremy. (2005). Calcium and the replication of human vascular smooth muscle cells: studies on the activation and translocation of extracellular signal regulated kinase (ERK) and cyclin D1 expression. European Journal of Pharmacology. 509(1). 21–30. 20 indexed citations

Fitzgerald, Katherine A., Daniel C. Rowe, & Douglas T. Golenbock. (2004). Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes and Infection. 6(15). 1361–1367. 269 indexed citations

10.

Fitzgerald, Katherine A., Daniel C. Rowe, Betsy Barnes, et al.. (2003). LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF. The Journal of Experimental Medicine. 198(7). 1043–1055. 979 indexed citations breakdown →

11.

McWhirter, Sarah M., Katherine A. Fitzgerald, Jacqueline Rosains, et al.. (2003). IFN-regulatory factor 3-dependent gene expression is defective in Tbk1 -deficient mouse embryonic fibroblasts. Proceedings of the National Academy of Sciences. 101(1). 233–238. 454 indexed citations

12.

Fitzgerald, Katherine A., Sarah M. McWhirter, L. Kerrie, et al.. (2003). IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunology. 4(5). 491–496. 2204 indexed citations breakdown →

13.

Rowe, Daniel C., Ainsley A. Culbert, & Jamie Y. Jeremy. (2000). Calcium Pool Status Controls Human Vascular Smooth Muscle Cell Proliferation Through Modulation of the ERK1/2 Axis and Cyclin D1 Expression. Biochemical Society Transactions. 28(5). A296–A296. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact